The betterment of well people

The betterment of well people is the proposal that psychedelic experiences might benefit people who are not ill, extending their use beyond treatment for conditions such as cancer-related distress, depression, or addiction. In the book, the phrase marks a fault line in the renewed debate over psychedelics: medical acceptance may open the door to wider cultural use, but the experience’s power and suggestibility make questions of guidance, integration, and institutional control inseparable from the question of who should have access.

From treatment to broader benefit

The proposal begins within clinical research but reaches beyond its immediate patient population. Researchers studying psychedelics for illness also consider whether people might seek them for spiritual exploration, curiosity, or the development of emotional and creative potential. Katherine MacLean voices the expansive version of this possibility: limiting psychedelics to patients would preserve the old medical model, whereas the drugs might have a broader application. That suggestion echoes the 1960s conviction that psychedelics could be useful to the well as well as the sick, and it unsettles colleagues wary of reviving the era’s rhetoric.

Bob Jesse and Rick Doblin are among the institutional outsiders more willing to discuss this wider horizon openly. For some advocates, medical acceptance would be a preliminary step toward legalization; for others, including Jesse and MacLean, wider availability would still require careful limits. Jesse imagines trained guides working in longitudinal, multigenerational contexts resembling churches, where experience is held within a continuing community rather than treated as a one-off clinical procedure. Julie Holland offers another possible setting: an occasional mental-health club, part retreat and part gym, where people could undergo psychedelic experiences in a safe, supportive environment. These are competing proposals for how to make access broader without making it unstructured.

What the experience might offer

The case for broader use is not simply that psychedelics can relieve symptoms. The NYU and Johns Hopkins cancer trials found clinically significant reductions in anxiety and depression for many participants, with effects lasting at least six months; the intensity of reported mystical experience closely correlated with the degree of symptom relief. Those findings give researchers reason to ask whether the experience itself, and not only a narrowly defined pharmacological effect, might matter to people beyond the sick. They do not establish that the same benefits follow for healthy participants, but they sharpen the question of what therapeutic or human value the experience may carry.

A follow-up study of NYU volunteers described a movement from separateness toward connection, often accompanied by joy, love, or bliss. Difficult passages could give way to surrender and acceptance, including acceptance of cancer. Jeffrey Guss interprets these changes through the psychedelic’s egolytic effects: as the ego’s usual boundaries between conscious and unconscious experience, or between self and other, soften, people may become less bound to rigid thought and more able to perceive new meanings. In preparing patients, Guss explicitly invites reflection on hidden aspects of the self and on life’s meaning, while refraining from prescribing what a mystical or transcendent experience must be. The account therefore places the guide and the language of preparation alongside the molecule in shaping what participants make of a session.

The possible value of that change is described in both humanistic and spiritual terms. A heightened sense of purpose may make the world feel less arbitrary and help a person situate the self within a larger context, whether understood as universal love or as connection with nature. The book presents this as especially important to people facing death, but also insists that existential fear is not confined to the dying. The argument for betterment thus concerns more than clinical symptom reduction: it asks whether an experience that alters meaning and perspective can be valuable without first being justified as a cure.

The limits of a medical frame

The expansion is difficult partly because psychedelic effects resist the methods by which medicine usually isolates a treatment’s action. Participants and guides can often tell whether psilocybin or a placebo was administered, making blinding difficult. Researchers also cannot easily separate the drug’s effects from set and setting, the therapists’ presence, or participants’ expectations. If a psychiatric intervention works partly by occasioning a particular kind of experience, conventional trials may struggle to identify what produced the outcome. The same features that may make the experience meaningful therefore complicate its evaluation as a medical treatment.

Its spiritual character adds another institutional challenge. Charles Grob describes psychedelic therapy as applied mysticism, a formulation that sits uneasily within a medical system increasingly committed to biochemical accounts of the mind. Franz Vollenweider calls the mystical element an interesting shamanic concept rather than a medical one, while Grob argues that research design should learn from shamanic practice as well as meet scientific standards. In that model, a guide deliberately attends to extra-pharmacological conditions, including the setting and the suggestibility of the participant. The dispute is not merely over whether psychedelics work, but over whether medicine can acknowledge the relational, spiritual, and experiential dimensions through which their effects may arise.

The book also situates this debate against older sacramental practices, whose use was driven underground in the Americas after Spanish conquest. That history cautions against treating psychedelic experience as a wholly new invention of modern clinics, while also underscoring that access has long been shaped by cultural authority and suppression. In the contemporary argument, the question is whether wider use can be developed with social forms sturdy enough to hold the experience, rather than simply transferring it from the clinic to the individual consumer.

Access, guidance, and integration

The alternative to medical restriction is not necessarily unrestricted individual use. The first generation of researchers tried several frameworks—psychotomimetic, psycholytic, psychedelic, and later entheogenic—each pairing a theory of the drugs with protocols for their use. The book treats these frameworks as imperfect containers for powerful compounds. Its central contrast is between guided approaches and the do-it-yourself use associated with Timothy Leary and the counterculture, which rejected the need for a medical, religious, or scientific container. Unguided use can be risky; other societies’ ritual practices suggest the importance of rules, a steadying community, and an experienced guide.

The underground practice described in the book illustrates one way that guidance continued after sanctioned psychedelic therapy ended. Its practitioners include credentialed therapists, religious professionals, and guides trained in varied therapeutic and spiritual traditions. Many trace their professional lineages to Timothy Leary, Stanislav Grof, Al Hubbard, or Leo Zeff. Because the work remains illegal, guides risk their freedom and professional licenses; those interviewed asked that their names, locations, and identifying details be changed. This account makes broader access a practical question of who can guide an experience and under what conditions, not simply a question of whether healthy people should be allowed to seek one.

Integration is another essential safeguard. Tony Bossis invokes Huston Smith’s observation that a spiritual experience by itself does not make a spiritual life: the experience has to be interpreted and incorporated if it is to become useful. The proposed future therefore depends on more than occasional access or clinical approval. It requires trained guides and meaningful support afterward, whether the setting is medical, communal, or spiritual. The betterment of well people remains an open aspiration, bounded by the book’s insistence that the potential benefits of these experiences cannot be separated from the structures that help people meet and make sense of them.